M. Kamionka

Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.

C. Renner, T. Holak, C. Klein, 2001, Biochemistry.

In silico and NMR identification of inhibitors of the IGF-I and IGF-binding protein-5 interaction.

Hans-Georg Beisel, Till Rehm, T. Holak, 2002, Journal of medicinal chemistry.

Engineering of Therapeutic Proteins Production in Escherichia coli

M. Kamionka, Mariusz Kamionka, 2011, Current pharmaceutical biotechnology.

The interaction of insulin‐like growth factor‐I with the N‐terminal domain of IGFBP‐5

T. Holak, R. Engh, W. Żesławski, 2001, The EMBO journal.

Specificity of the Interaction between Ubiquitin-associated Domains and Ubiquitin*

J. Feigon, T. Mueller, M. Kamionka, 2004, Journal of Biological Chemistry.

Structure of the XPC binding domain of hHR23A reveals hydrophobic patches for protein interaction

J. Feigon, M. Kamionka, 2004, Protein science : a publication of the Protein Society.

Structural Investigations on Proteins Involved in Cancer Development

M. Kamionka, 2001 .

Welcome Statement by the Chair

A. Healy, M. Radomski, M. Henman, 2009 .